Omar Boraie Helps Advance Precision Medicine
An important field in medical sciences is getting a new boost from Omar Boraie, who has contributed 1.5 million dollars to Rutgers University in New Brunswick, New Jersey. These new funds are being used to bring a new chair to the Genomic Science Department where physician scientists are working to advance the field of precision medicine.
The Omar Boraie Chair in Genomic Science has been created to help researchers and physicians research new methods of treating patients using a specific treatment based on the patient’s genome. Creating an individualized treatment system for each patient helps ensure a better outcome, and eliminates many of the negative side effects from more generalized treatment therapies.
A better understanding of the human genome along with reduced cost in producing complete sequences of patients DNA has allowed scientists to look at precision medicine as a real alternative when treating patients. Rare cancers, hard to treat cancers, and those who have very limited paths of treatment will benefit from a personalized therapy. Looking at the complete sequence of a person’s genome will also allow physicians to ensure that they will not lead a person into a different illness when treating.
Boraie has long been interested in cancer research, and hopes that his contribution will inspire others to contribute to this vital research. The Omar Boraie chair is a part of an ’18 chair challenge’ started by an anonymous donor willing to match donations of $1.5 million for each of 18 chairs. This challenge has so far resulted in $3 million to the Cancer Institute at Rutgers. The New Jersey university has established themselves as a founding institution to integrate genomic sciences with precision medicine, and continues to be the only institute to do so in the garden state.
Shridar Ganesan, MD, PhD, has been named to the newly established chair. Dr. Ganesan is a well regarded oncologist who has been with Rutgers since 2005, and plays a crucial role in the field. The new chair member stresses the importance of understanding how diseases like cancer are not just a single illness, but instead are a collection of diseases.
To find out more information about Rutgers work with genomic sciences, Omar Boraie, or Shridar Ganesan check out the article that has been published through NewsWise.